IAG . Bankinter Fija su Precio Objetivo en 3,50€ Por Acción . En Marcha la Recompra de Acciones . : Sold by Schering-Plough in Europe as Caelyx and by J&J unit Ortho Biotech in the USA as Doxil, in combination with PharmaMar's own lead compound Yonde